When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NBRV - Nabriva strikes out again on FDA nod for fosfomycin
Nabriva Therapeutics plc
Nabriva Therapeutics (NASDAQ:NBRV) has received a CRL from the FDA in response to its refiled marketing application seeking approval of Contepo (fosfomycin) for the treatment of complicated urinary tract infections, including pyelonephritis (urinary tract infection that has traveled to the kidney).
More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stocks on the move,